Background Few data exist on the comparative safety and immunogenicity of different
COVID-19 vaccines given as a third (booster) dose. To generate data to optimise selection of …

The treatment of tuberculosis is based on combinations of drugs that directly target
Mycobacterium tuberculosis. A new global initiative is now focusing on a complementary …

Objectives To describe trends in major communicable diseases in Syria during the ongoing
conflict, and the challenges to communicable disease surveillance and control in the context …

Background Some high-income countries have deployed fourth doses of COVID-19 vaccines,
but the clinical need, effectiveness, timing, and dose of a fourth dose remain uncertain. We …

Despite concerted efforts over the past 2 decades at developing new diagnostics, drugs,
and vaccines with expanding pipelines, tuberculosis remains a global emergency. Several …

Aim: To determine the role of CT-guided biopsy in the management of cases of infective
discitis. Methods: Data were examined from a retrospective case series of CT-guided biopsies …

Objective To describe the characteristics and outcomes of patients with a clinical diagnosis
of COVID-19 and false-negative SARS-CoV-2 reverse transcription-PCR (RT-PCR), and …

Background Vaccination against COVID-19 continues apace, but side-effects, both common
and severe, continue to be reported. We report here the first published case of COVID-19 …

Introduction Age-related immunosenescence influences the presentation of tuberculosis (TB)
in older patients. Here, we explore the clinical and radiological presentation of TB in the …

During the autumn of 2022, both the US Centers for Disease Control and Prevention and
the UK’s Joint Committee on Vaccination and Immunisation recommended the targeted …